Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Financial results ....
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures has informed the exchanges that its Board of Directors will meet on Thursday, August 14, 2025 via video conferencing. The main item on the agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). The company has also reminded that the trading window for insiders remains closed until 48 hours after the results are declared. No financial figures, estimates or business updates have been disclosed in this filing, as it is a routine pre-results intimation under SEBI LODR regulations.
This is a standard advance notice and carries no direct impact on the stock. Investors should watch the actual Q1 FY26 results announcement on or after August 14 for revenue, profit and margin trends.